Although the involvement of autophagy in the onset of autosomal dominant polycystic kindey disease (ADPKD) has been largely demonstrated, only modulators of mTOR and AMPK activity have been tested in clinical studies for the treatment of ADPKD. This evidence concerns the gene MTOR and autosomal dominant polycystic kidney disease.